Read-onlySigned in as demo@nsight.app
As of 10 Oct 2026 · demonstration dates
Portfolio reports show the current active book. Closed and archived borrowers, including their history, are available in All Borrowers.
BluePeak Healthcare Solutions
Valuation support — Q3 2026
Marks received: 1/1 credit positions; 0/0 equity positions. Totals include known marks only. LTM analysis requires four consecutive financial quarters.
$22.1M
Credit FV · Q3 2026
+$0.1M
vs Q2 2026
0.98x
Credit FV / LTM EBITDA
$22.5M
LTM EBITDA (unadjusted)
Tight
Binding Covenant
Mark against Credit
Credit fair value ($M)$22.1M latest
21.521.821.222.022.1
Interest Coverage cushion (%)
———11.415.0
Minimum LTM EBITDA ($M) cushion (%)
———4.27.1
Total Leverage cushion (%)
———11.413.8
Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Method and Assumptions
| Quarter | Credit FV | Method | Note |
|---|---|---|---|
| Q3 2025 | $21.5M | Not documented | — |
| Q4 2025 | $21.8M | Not documented | — |
| Q1 2026 | $21.2M | Not documented | — |
| Q2 2026 | $22.0M | Market comparable | EV/EBITDA 7.0x; recovery trajectory reflected |
| Q3 2026 | $22.1M | Market comparable | Reviewed source: Holdings and Marks!G2; 22.1 |
Valuation Events
No amendments, waivers, PIK flips or sponsor injections recorded.